关键信息
-
基因名
BTBD2
- 应用
-
别名
BTBD2; BTB/POZ domain-containing Protein 2
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BX70
-
表达区间
1-525aa
-
氨基酸序列
MAAGGSGGRA SCPPGVGVGP GTGGSPGPSA NAAATPAPGN AAAAAAAAAA AAAAPGPTPP APPGPGTDAQ AAGAERAEEA AGPGAAALQR EAAYNWQASK PTVQERFAFL FNNEVLCDVH FLVGKGLSSQ RIPAHRFVLA VGSAVFDAMF NGGMATTSTE IELPDVEPAA FLALLKFLYS DEVQIGPETV MTTLYTAKKY AVPALEAHCV EFLKKNLRAD NAFMLLTQAR LFDEPQLASL CLENIDKNTA DAITAEGFTD IDLDTLVAVL ERDTLGIREV RLFNAVVRWS EAECQRQQLQ VTPENRRKVL GKALGLIRFP LMTIEEFAAG PAQSGILVDR EVVSLFLHFT VNPKPRVEFI DRPRCCLRGK ECSINRFQQV ESRWGYSGTS DRIRFSVNKR IFVVGFGLYG SIHGPTDYQV NIQIIHTDSN TVLGQNDTGF SCDGSASTFR VMFKEPVEVL PNVNYTACAT LKGPDSHYGT KGLRKVTHES PTTGAKTCFT FCYAAGNNNG TSVEDGQIPE VIFYT
-
分子量
55 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
BTBD2 (BTB (Broad-Complex, Tramtrack, and Bric-a-Brac) domain containing 2) is a member of the BTB/POZ domain-containing protein family, which plays critical roles in multiple biological processes, including cellular differentiation, signal transduction, and transcriptional regulation. Research has indicated that BTBD2 may be involved in various disease states, including cancer and neurodegenerative disorders, due to its potential role in modulating gene expression and protein interactions. Given its significant biological functions, BTBD2 has drawn attention as a potential therapeutic target. Recent advances in recombinant protein technology have facilitated the production and study of BTBD2, allowing researchers to investigate its biochemical properties, structure-function relationships, and interactions with other proteins. This research could provide valuable insights into the mechanisms underlying its functions and the pathophysiology of related diseases. Understanding the role of BTBD2 through the study of its recombinant protein not only enhances our fundamental knowledge of cellular processes but also holds promise for the development of novel therapeutic strategies aimed at diseases associated with dysregulated BTBD2 activity.
